Десмоидные фибромы у лиц мужского пола
Диссертация
В настоящее время появляется все больше доказательств роли гормональных факторов" в развитии ДФ. До недавнего времени считалось, что эти опухоли встречаютсяпреимущественно у молодых женщинзначительно реже у мужчин и крайне редко у детей. Однако исследования последних лет подтвердили, что преобладание больных женского пола в структуре заболеваемости агрессивным фиброматозом не столь значительно… Читать ещё >
Список литературы
- Бец JI.B. «Гормональный портрет» человека. Природа, 2005, № 1
- Вейзе Д.Л. Ультразвуковая диагностика опухолей мягких тканей. Дисс.к.м.н., М, 1996
- Глебовская В. В. Терморадиотерапия больных с первичным и рецидивным экстраабдоминальным десмоидом. Дис. к.м.н. М., 2004. — 104 с.
- Дарьялова С.Л., Кузнецова М. А. Волченко H.H. Комбинированное лечение экстраабдоминальных десмоидов. Медицинская радиология 1983- 10: 18−22
- Дедов И.И., Мельниченко Г. А., Фадеев В. В. Эндокринология. М, «Медицина», 2000, с.601
- Ковалев А.И., Залуцкий И. В., Фрадкин С. З., Будник A.A. Диагностика и лечение интраабдоминальных десмоидов. Здравоохранение, № 7, 200 Г, 54−57
- Ковалев Д.В., Колосов П. В. Агрессивный фиброматоз: современное состояние проблемы. Анналы хирургии 2002- 4: 13−16
- Кузнецова М.А. Роль лучевой терапии в лечении десмоидных фибром мягких тканей. Дисс. канд., М., 1986
- Морозова C.B. Разработка консервативных методов лечения десмоидных фибром. Дисс. к.м.н. М., 2004.-154с.
- Ю.Никитин A.M., Чубаров Ю. Ю., Обухов В. К., Якушин A.B. Лечебная тактика при десмоидах у больных диффузным полипозом толстой кишки. Вопросы онкологии 1991- 37 (11−12): 1098−102
- П.Ольховская И. Г., Карапетян P.M. К вопросу об экстраабдоминальных десмоидах. Опухоли опорно-двигательного аппарата, т.4, М, 1973, 16 817 112.0льховская И. Г. Фибробластические опухоли мягких тканей опорно-двигательного аппарата. Дисс. докт., М., 1977
- Переводчикова Н.И. Руководство по химиотерапии опухолевых заболеваний. М. «Практическая медицина», 2005, с.672−693
- Петрова С.В., Райхлина Н. Т. Руководство по иммуногистохимической диагностике опухолей. Казань, 2004, глава 21, с.201−203
- Раков А.И., Чехарина Е. А. Злокачественные опухоли мягких тканей конечностей и туловища. JL, «Медицина», 1968, с.74−78
- Сергеев С.И., Лавникова Г. А., Колобяков А. А. Экстаабдоминальные десмоиды. Хирургия, 1976, № 4, с.3−8
- Тиц Н. Энциклопедия клинических лабораторных тестов. М, «Лабинформ» 1997, с.942
- Чиссов В.И., Дарьялова С. Л. с соавт. Десмоидные фибромы. Готовы ли мы отказаться от хирургического лечения. Вестник травматологии и ортопедии им. Н. Н. Приорова 1998, 1: 112L117
- Шлопов В.Г. Клинико-морфологическая характеристика десмоидов. Клиническая хирургия, 1968, № 12: 44−47
- Abramovitz D, Zornova J et al. Soft tissue desmoid tumours: radiographic bone changes. Radiology, 1983, 146, № 1: 11−13
- Alman В A, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumors). Am J Pathol 1997- 151: 329−334
- Azzarelli, Gronchi, Bertulli, Tess, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001- 92: 1259−1264
- Bahk WJ, Kang YK, Lee AH, Mirra JM. Desmoid tumor of bone with enchondromatous nodules, mistaken chondrosarcoma. Skeletal Radiol, 2003 Apr- 32(4):223−6
- Baliski CR, Temple WJ, Arthur K, Shachar NS. Desmoid tumors: a novel approach for local control. J Surg Oncol 2002- 80(2): 96−9
- Ballo MT, Zagars GK, Pollack A, Pisters P, Pollock R. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy or combined surgery and radiation therapy. J Clin Oncol 1999- 17: 158−167
- Bauernhofer T, Stoger H- Schmid M, et al. Sequential treatment of recurrent mesenteric desmoid tumor. Cancer 1996- 77: 1061−1065
- Blackwell KL, Haroon ZA, Shan S, et al. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000- 6: 4359−64
- Bodmer> WF, Bailey CJet al. Localisation of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987- 328:614−16
- Brancato G, Donati M, Privitera Aet al. Current approach in the treatment of desmoid tumors of the abdominal wall. Chir Ital 2001 Sep-Oct- 53(5): 697 704
- Braunstein GD. Aromatase and gynecomastia. Endocrine-Related Cancer 1999- 6:315−324
- Brey G.A., Fisler J.S., York D.A. Neuroendocrine control of development of obesity: understanding gained from studies of experimental animal models. //Front Neuroendocrinol. -1990. -Vol*. 11. -P. 128−81
- Brooks MD, Ebbs SR, Colletta AA, Baum.M. Desmoid tumors treated with triphenylethylenes. Eur J Cancer 1992- Vol 28A, № 6/7: 1014−1018
- Brueckl WM, Ballhausen’WG, Fortsch T et al. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum 2005- 48: 1275−1281
- CaspariR, Olschwang S, Frield W et al. Familial adenomatous polyposis: desmoid tumor/and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995- 4:337−40
- Chew C, Reid R, O Dwyer PJ. Evaluation of the long term outcome of patients with extremity desmoids. J of Cancer Surgery 2004- 30:428−432
- Clare SK, Philips RKS. Desmoids in-familial adenomatous polyposis. British Journal of Surgery 1996- 83:1494−1504
- Clark SK, Smith TG, Katz DE et al. Identification and progression of a desmoid precursor lesion in patients with familial’adenomatous polyposis. Br J Surg 1998- 85 (7): 970−3
- Clark TW. Percutaneus chemical ablation of desmoid tumours. J Vase Interv Radiol 2003- 14: 629−633
- Couture J, Mitri A et al. A germline mutation at the extreme 3 end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 2000- 57 (3): 205−12
- Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995 Mar*30- 31(5): 1341−46
- D Souza, Kulkarni DV, Patel. B, Shivraman A. Muscloaponeurotic fibromatosis of both bones of forearm. J Postgrad Med, 1996, Vol.42*- 2:57−9
- Dahn I, JoussonN, Lundh G. Desmoid tumours: A series of 33 cases. Acta ChirScand 1963- 126: 305−314
- Dalen>M- Bergh M, Gunterberg B. Desmoid tumors. A clinical review of 30 patients with more than 20 years follow-up. Acta Orthop Scand 2002, Apr- 73(2):213−9
- Dalen, Berg, Gunterberg. Desmoid Tumors. Acta Orthop Scand 2003- 74(4):455−459i
- Dorfinan HD, CzerniakB. Bone tumors. St. Louis: Mosby 1998:514−529
- Dormans JP, Spiegel D, Meyer J et al: Fibromatosis in childhood: the desmoid fibromatosis complex. Med Pediatr Oncol-2001- 37: 126−131
- DuttSN, Mirza S, Irving RM, Jones EL. Desmoplastic fibroma of the temporal bone. J Laringol Otol, 2000 Apr- 114(4): 314−7
- Elias D, Prezioso GP, Goharin A et al. Treatment of desmoid tumors of the mesenteric root. Press Med 2000 Mar 4- 29(8): 408−12'
- Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop 1986- 204:9−24
- Enzinger FM, Weiss SW, editors: Soft tissue tumors. St Louis: Mosby, 1990
- Ewing J. Neoplastic Diseases. 2ndledn. Philadelphia: W.B. Saunders, 1928
- Faria SC, Iyer RB, Rashid A, Ellis L, Whitman GJ. Desmoid tumor of the small bowel and mesentery. Radiologic-Pathologic Conferens of the University of Texas. M.D. Anderson’Cancer Center. 2004 July- 118
- Faulkner LB, Hajdu SI, Kher U et al. Pediatric desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol 1995- 13: 2813−8.
- Ferah Y, Ayse K et ah Possible therapeutic role of vitamin D3 in aggressive fibromatosis. Jpn J Clin Oncol 2004- 34(8): 472−475
- Fletcher DM, Unni K, Mertens F. World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of Soft Tissue and Bone. I ARC Press, Lyon 2002.
- Fujimoto Y, Hidai K. Aggressive fibromatosis in the neck. A case treated effectively by testolactone with a long follow-up study. Jpn J Surg 1990- 20: 453−457
- Galle TS, Juel K, Bulow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999- 34p (8): 808−12
- Gansaar GF, Krementz ET. Desmoid tumours: experience with new modes of therapy. South Med J" 1998- 81: 794−796 '
- Gega M, Yanagi H, Yoshikawa R et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumours in association with familial adenomatous polyposis. J Clin Oncol 2006- 24(1): 102−5
- Giarola M, Wells D, Mondini P et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998- 78 (5): 582−587
- Goepfert H, Cangir A, Ayala AGiet al. Chemotherapy of locally aggressive head’and neck tumors in the pediatric group. Am J Surg 1982- 144: 437−444
- Goy BW, Lee SP, Eilber F et al. The role of adjuvant radiotherapy in the treatment’of resectale desmoid tumors. Int J Radiat Oncol Biol Phys 1997- 39: 659−65
- Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994- 35: 377−81
- Gurbuz AK, Giardiello FM, Petersen GM, et al: Desmoid tumours in familial adenomatous polyposis. Gut 1994- 35: 377−81
- Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004- 100: 612−20
- Havry P, Reitamo JJ, Totterman S et al. The desmoid tumor. II. Analysisof factors possibly contributing to the etiology and growt h behavior. Amer J Clin Pathol 1982a- 77: 674−680
- Heidemann J, Ogawa H et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum 2004- 47:118−122
- Ho JW, Chu KM, Tse CW, Yuen ST. Phenotipe and management of patients with familial adenomatous polyposis in Hong-Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J 2002 Oct- 8(5): 342−7
- HoosA, Lewis JJ, Urist MJ et al. Desmoid Tumors of the head and neck: a clinical studu of a rare entity. Head Neck, 2000- 22:81 474.1nwards JY, Unni KK, Beabout JW, Sim FH. Desmoplastic fibroma of bone.
- Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Annals of Oncology 2003- 14: 181−190^
- Jelinek JA, Stelzer KJ et al. The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiation Oncology Biol Phys, 2001, Vol.50 N1:121−125
- Jones IT, Fazio VW, Weakley FL, Jagelman DG, Lavery IC, McGannon E. Desmoid tumors in familialpolyposis coli. Ann Surg 1986- 204: 94−107
- Juergens KU, Bullmann V et al. Desmoplastic fibroma in the thoracic spine: an unusual localization of rare primary bone tumor. Eur Radiol, 2001- 11(2): 273−5
- Kendi TK, Erakar A, et al. Desmoplastic fibroma of bone: A case report. Clinical Imaging, 2003 Vol. 27- 3:200−202
- Khorsand J, Karakousis D. Desmiod tumors and their management. Am J Surg 1985- 149: 215−218
- Kiel KD, Suit HD. Radiation therapy in the treatment of aggressive fibromatosis (desmoid tumors). Cancer 1984- 54: 2051−5
- Kinzbrunner B, Ritter S, Domingo J et al. Remission of rapidly growing* desmoid tumors after tamoxifen therapy. Cancer 1983- 52: 2201−2204
- Klaase JM, KroonBB, Benckhuijsen C et al. Results of regional’isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer 1989- 64: 616−621
- KnudsenAL, Bulow S. Desmoid tumor in familial adenomatous polyposis. Ugeskr Laeger 2000 Oct, 16- 162(42): 5628−31
- Lackner H, Urban C, Benesch M., et al. Multimodal treatment of children1 with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study. //J Pediatr Hematol Oncol. -2004. № 26. -C. 518−522.
- Leder BZ, Rohrer JL. Effects of aromatase inhibitors in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab 2004- 89(3): 1174−80
- Leithner A, Gapp M et al. Margins in extra-abdominal desmoid tumors: a comparative analysis. J Surg Oncol 2004- 86:152−156
- Leithner A, Schnack B, Katterschafka T et al. Treatment of extra-abdominal desmoid tumours with interferon-alpha with or without tretinoin. J Surg Oncol 2000 Jan- 73(1): 21−5
- Lev-Chelouche D, Abu-Abeid, Nakache R et al. Limb desmoid tumours: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Surgery 1999- 126: 963−967
- Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid-tumors. Ann Surg 1999- 229 (6): 866−73
- Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid-fibromatosis is a clonal process. Hum Pathol 1996 Sep- 27(9):939−43'
- Lipschutz A. Steroid hormones and tumors. Williams & Wilkins, Baltimore, 1950
- Lotfi AM, Dozois RR, Gordon H, et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: Predisposingfactors and results of treatment. Int XColorect Dis 1989- 4: 30−36
- Mace J, Biermann JS, Sondak V et al. Response of extraabdominal’desmoid tumours to therapy with imatinib mesylate. Cancer 2002- 95:2373−9
- McFarlane J. Clinical reports on the surgical practice of the Glasgow Royal Infirmany. Glasgow, D. Robertson, 1832, 63−66
- Mehrotra AK, Sheikh S, Aaron AD, Montgomery E, Goldblum JR. Fibromatoses of the extremities: clinicopathologic study of 36>cases. J Surg Oncol^OOO- 74 (4): 291−6
- Mendenhall WM, Zloteski RA, Morris CG et al. Aggressive fibromatosis. Am J Clin Oncol 2005- 28:211−215
- Mendez-Fernandez MA, Gard DA. The desmoid tumor: benign neoplasm, not a benign disease. Plast Reconstr Surg 1991- 87: 956−960
- Micke O, Seegenschmiedt. Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national’patterns of care study. Int J Radiation Oncology Biol Phys, 2005 Vol. 61, № 3:882−891
- Muller J, Ueber den feinen Bau und die Formen der krankhaften Geschwulste.(Aboutthe fine structure and types of pathological tumors). Berlin: Reimer G. Erste Lieferung. 1838: 60
- Nieschlag E, Swerdloff R, Behre HM et al. Investigation, treatment and-monitoring of late-onset hypogonadism in males: ISSAM, ISA and EAU recommendations. Androl, 2006 Mar-Apr- 27(2): 135−7
- Nuyttens JJ, Rust PF, Thomas. CR, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. Cancer 2000- 88:1517−23
- Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumours. Cancer 2003- 97:1134−35
- Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993- 72:3244−3247
- Pignatti’G, Barbanti-Brodano G, Ferrari D et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop 2000- 375: 207−13
- Pikaar A- Nortier JW- Griffioen G- Vasen HF Desmoid tumors in patients with familial adenomatous polyposis Ned Tijdschr Geneeskd 2002 Jul 20- 146(29): 1355−9
- Pilz T, Pilgrim TB, Bisogno G et al. Chemotherapy in fibromatosis of childhood and adolescence: results from the cooperative soft tissue sarcoma study (CWS) and Italian cooperative study group (ICG-AIEOP). Clin Pediatr 1999 Jul-Aug- 211(4): 291−5
- Plourde PV, Reiter EO et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004 Vol 89- No 9: 4428−4433″
- Poritz LS, Blackstein M, Berk T et al. Extended follow-up of patients treated with cytotoxic chemotherapy for intraabdominal desmoid tumours. Dis Colon Rectum 2001, Sep-44(9): 1268−73
- Pritchard DJ, Nascimento AG, Peterson IA. Local control of extraabdominal desmoid tumors. J Bone Joint Surg Am 1996-, 78: 848−54
- Procter H, Singh L, Baum M et al. Response of multicentric desmoid tumors to tamoxifen. Br J: Surg 1987- 746 401″
- Raguse JD, Gath HJ, Oettle H- Bier J. Interferon-indused remission of rapidly growing aggressive fibromatosis in the temporal fossa. Oral Maxillofac Surg 2004- 33:606−609
- Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002- 167 (2 Pt 1): 624−9
- Ramsey RH. The pathology diagnosis and treatment of extra-abdominal desmoid tumors. J Bone Jt Surg 1955, 37a: 1012−1018
- Raney B, Evans A, Granowetter L et al: Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics 1987- 79: 394−398
- Reich S, Overberg-Schmidt US, et al. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol, 1999, Vol 17- 3:1086
- Reis-Filho JS- Milanezi F- Pope LZ- Fillus-Neto J- Schmitt FC Primary fibromatosis of the breast in a patient with multiple desmoid tumors—report of a case with evaluation of estrogen and progesterone receptors. Pathol Res Pract 2001- 197(11):775−9
- Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982- 77: 665−73
- Reitamo JJ, Scheinin TM, Havry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am j Surg 1986- 151:230−237
- Rock MG, Pritchard DJ, Reiman HM et al. Extra-abdominal desmoid tumors: J Bone Joint Surg Am 1984- 66A: 1369−1374
- Ronde W, Schouw YT, Muller M et al. Associations of sex-hormone-binding globulin.(SHBG) with non-SHBG-bound levels of testosterone and estradiol in-independently living men. Journal of Clinical Endocrinology and Metabolism, 2005'Vol. 90, 1:157−162
- Scapec SX, Hawk BJ, Hoffer FA et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid’tumour in children. J Clin Oncol 1998- 16: 3021−3027
- Schnitzler M, Cohen Z, Blackstein M et al. Chemotherapy for desmoid* tumours in association-with familial adenomatous polyposis. Dis Colon Rectum 1997- 40:798−80r
- Schultz-Ertner D- Zierhut D, Mende U, Harms W et al. The role of radiation therapy in the management of desmoid tumors. Strahlenther Oncol 2002- 178 (2): 78−83
- T39.v Sodergard R, BackstormTet al. Calculation of free and bound fractions of testosterone and estradiol-17/3 to human plasma proteins at body temperature. ISteroidsBiochemil982v 16:801−810/
- Soravia C, Berk T, McEeod? RS- Cbhen=Z. Desmoid disease in patients with familial) adenomatous-polyposis. Dis Colon Rectum 2000Mar- 43(3): 363−9
- Sorensen A, Keller J-Nielsen OS, JensenOM: Treatment ofaggressive: fibromatosis: a retrospective studu of 72 patients followed for 1−27 years. Acta Orthop Scand 2002, Apr- 73(2):213−9
- Speroff E,. Fritz MA. Clinical Gynecologic Endocrinology and lnfertility. Seventh Edition. Lippuncott Williams and Wilkins, 2005
- SpiegelDA, Doirnans? JP?etalLAggressive Fibromatosis, fromlnfancytoi Adolescence. Journal of Pediatric Orthopaedics 1999- 19:776−784
- Sportiello DJ- HoogerlandlDE. A recurrent pelvic desmoiditumor successfully treated with tamoxifen. Cancer 1991- 67: 1443−1446
- Stein R. Chemotherapeutic response in fibromatosis of the neck. J Pediatr 1977- 90:482−483
- Stojadinovic A, Hoos A, Karpoff HM et alt Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg 2001 Jan- 136(1): 70−9
- Tonelli F, Valanzano R, Brandy ML. Pharmacologic treatment of desmoid tumours in familial adenomatous polyposis: results of an in vitro study. Surgery 1994- 115: 473−9 i
- V. Tsukada K, Church JM, Jagelman DG et al: Systemic cytotoxic chemotherapy and’radiation therapy for desmoids adenomatous polyposis: Dis Colon Rectum 199 V- 34: 1090−1092:
- Waddell WR, Kirsch WM. Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors: Am J Surg 1991- 161:416−421
- Wehl G, Rossler J et al. Response of progressive fibromatosis to therapy with liposomal doxorubicin. Oncologic 2004- 27:552−556
- Weiss AJ- Lackman RD. Low-dose chemotherapy of desmoid tumours. Cancer 1989- 64: 1192−1194
- Wilcken N, Tattersall MHN. Endocrine therapy for desmoid tumors. Cancer 1991- 68: 1384−1388
- Yildiz F, Kars A, Cengiz M et al. 1,25-dihydroxy vitamin D3: can it be an effective therapeutic option for aggressive fibromatosis. Medical Hypotheses 2005- 64: 333−336